Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Hsu

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
JACC. Clinical Electrophysiology|May 16, 2018
Cardiac Tamponade From Permanent Pacemaker Implantation: Is the Pressure Building?Jonathan C Hsu
Clinical Cardiology|July 16, 2015
Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused ReviewBoris Arbit, Jonathan C Hsu
The American Journal of Cardiology|November 15, 2017
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal DiseaseMarin Nishimura, Jonathan C Hsu
Cardiac Electrophysiology Clinics|August 4, 2017
An Unusual Case of Pacemaker MalfunctionJonathan C Hsu, Nora Goldschlager
Journal of the American College of Cardiology|January 14, 2017
A Cautionary Tone Before Expanded Adoption of the Proposed CHA<sub>2</sub>DS<sub>2</sub>-VASc R ScoreMarin Nishimura, Jonathan C Hsu
JACC. Clinical Electrophysiology|January 24, 2020
Left Atrial Appendage Triggers in Atrial Fibrillation: How Often Are They the Source?Jonathan C Hsu, Florentino Lupercio
Journal of the American College of Cardiology|June 29, 2019
Valvular Atrial Fibrillation: A Confusing and Obsolete DefinitionShaun Giancaterino, Jonathan C Hsu
Journal of the American College of Cardiology|October 9, 2012
Colchicine after pulmonary vein isolation to prevent the early recurrence of atrial fibrillation: mollifying an inflammatory response?Gregory M Marcus, Jonathan C Hsu
Clinical Pharmacology and Therapeutics|July 15, 2018
Response to: "Enlisting Emergency Medicine Clinicians to Help Reduce Strokes in High-Risk Patients With Atrial Fibrillation and Flutter"Jonathan C Hsu, James V Freeman
Clinical Pharmacology and Therapeutics|January 13, 2018
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary ReviewJonathan C Hsu, James V Freeman
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
JACC. Clinical Electrophysiology|May 16, 2018
Cardiac Tamponade From Permanent Pacemaker Implantation: Is the Pressure Building?Jonathan C Hsu
Clinical Cardiology|July 16, 2015
Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused ReviewBoris Arbit, Jonathan C Hsu
The American Journal of Cardiology|November 15, 2017
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal DiseaseMarin Nishimura, Jonathan C Hsu
Cardiac Electrophysiology Clinics|August 4, 2017
An Unusual Case of Pacemaker MalfunctionJonathan C Hsu, Nora Goldschlager
Journal of the American College of Cardiology|January 14, 2017
A Cautionary Tone Before Expanded Adoption of the Proposed CHA<sub>2</sub>DS<sub>2</sub>-VASc R ScoreMarin Nishimura, Jonathan C Hsu
JACC. Clinical Electrophysiology|January 24, 2020
Left Atrial Appendage Triggers in Atrial Fibrillation: How Often Are They the Source?Jonathan C Hsu, Florentino Lupercio
Journal of the American College of Cardiology|June 29, 2019
Valvular Atrial Fibrillation: A Confusing and Obsolete DefinitionShaun Giancaterino, Jonathan C Hsu
Journal of the American College of Cardiology|October 9, 2012
Colchicine after pulmonary vein isolation to prevent the early recurrence of atrial fibrillation: mollifying an inflammatory response?Gregory M Marcus, Jonathan C Hsu
Clinical Pharmacology and Therapeutics|July 15, 2018
Response to: "Enlisting Emergency Medicine Clinicians to Help Reduce Strokes in High-Risk Patients With Atrial Fibrillation and Flutter"Jonathan C Hsu, James V Freeman
Clinical Pharmacology and Therapeutics|January 13, 2018
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary ReviewJonathan C Hsu, James V Freeman
Pageof 18